Hepatitis B/C and HIV in sub-Saharan Africa: An association between highly prevalent infectious diseases. A systematic review and meta-analysis

dc.contributor.authorBarth R.E.
dc.contributor.authorHuijgen Q.
dc.contributor.authorTaljaard J.
dc.contributor.authorHoepelman A.I.M.
dc.date.accessioned2011-05-15T16:16:44Z
dc.date.available2011-05-15T16:16:44Z
dc.date.issued2010
dc.description.abstractObjectives: Hepatitis B virus (HBV), hepatitis C virus (HCV), and the human immunodeficiency virus (HIV) are endemic in Africa. However, hepatitis co-infection rates among HIV-infected individuals remain controversial. The aim of this review was to determine the prevalence of HBV and HCV in HIV-infected patients in sub-Saharan Africa and to analyze whether HIV is associated with a higher HBV/HCV prevalence in that region. Design and methods: We performed a systematic review and meta-analysis. Studies reporting HBV and HCV prevalence data amongst HIV-infected patients in sub-Saharan Africa were included. Weighted means and medians across studies were calculated. Studies including an HIV-negative control group were used for meta-analysis. Risk ratios (RRs) were calculated using a random effects model. Results: Sixty studies were included. Among HIV-infected individuals, mean HBsAg and anti-HCV prevalence rates were 15% and 7%, respectively. RRs for a positive HBsAg and a positive anti-HCV were 1.40 (95% confidence interval (CI) 1.16-1.69) and 1.60 (95% CI 1.05-2.45) for HIV-infected, as compared to HIV-uninfected, patients. Conclusions: Many HIV-positive individuals in sub-Saharan Africa are HBV or HCV co-infected. HIV is associated with a higher prevalence of both HBV and HCV in this region. However, this association is less evident than that observed in Western countries and varies between studies. © 2010 International Society for Infectious Diseases.
dc.description.versionReview
dc.identifier.citationInternational Journal of Infectious Diseases
dc.identifier.citation14
dc.identifier.citation12
dc.identifier.issn12019712
dc.identifier.other10.1016/j.ijid.2010.06.013
dc.identifier.urihttp://hdl.handle.net/10019.1/13909
dc.subjecthepatitis B antigen
dc.subjecthepatitis C antigen
dc.subjectAfrica
dc.subjectdisease association
dc.subjecthepatitis B
dc.subjecthepatitis C
dc.subjecthigh risk population
dc.subjecthuman
dc.subjectHuman immunodeficiency virus infected patient
dc.subjectHuman immunodeficiency virus infection
dc.subjectmeta analysis
dc.subjectmixed infection
dc.subjectprevalence
dc.subjectreview
dc.subjectrisk assessment
dc.subjectsystematic review
dc.subjectAfrica South of the Sahara
dc.subjectHepacivirus
dc.subjectHepatitis B
dc.subjectHepatitis B virus
dc.subjectHepatitis C
dc.subjectHIV Infections
dc.subjectHIV-1
dc.subjectHumans
dc.subjectPrevalence
dc.titleHepatitis B/C and HIV in sub-Saharan Africa: An association between highly prevalent infectious diseases. A systematic review and meta-analysis
dc.typeReview
Files